These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26111462)

  • 1. Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells.
    Reinisch A; Chan SM; Thomas D; Majeti R
    Semin Hematol; 2015 Jul; 52(3):150-64. PubMed ID: 26111462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
    Marchand T; Pinho S
    Front Immunol; 2021; 12():775128. PubMed ID: 34721441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
    Hoang VT; Zepeda-Moreno A; Ho AD
    Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.
    Jin L; Lee EM; Ramshaw HS; Busfield SJ; Peoppl AG; Wilkinson L; Guthridge MA; Thomas D; Barry EF; Boyd A; Gearing DP; Vairo G; Lopez AF; Dick JE; Lock RB
    Cell Stem Cell; 2009 Jul; 5(1):31-42. PubMed ID: 19570512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
    de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L
    Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches.
    Thakral D; Gupta R; Khan A
    Stem Cell Rev Rep; 2022 Jun; 18(5):1756-1773. PubMed ID: 35412219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia.
    Hybel TE; Jensen SH; Rodrigues MA; Hybel TE; Pedersen MN; Qvick SH; Enemark MH; Bill M; Rosenberg CA; Ludvigsen M
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs.
    Boyd AL; Campbell CJ; Hopkins CI; Fiebig-Comyn A; Russell J; Ulemek J; Foley R; Leber B; Xenocostas A; Collins TJ; Bhatia M
    J Exp Med; 2014 Sep; 211(10):1925-35. PubMed ID: 25180064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
    Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia.
    Menendez-Gonzalez JB; Vukovic M; Abdelfattah A; Saleh L; Almotiri A; Thomas LA; Agirre-Lizaso A; Azevedo A; Menezes AC; Tornillo G; Edkins S; Kong K; Giles P; Anjos-Afonso F; Tonks A; Boyd AS; Kranc KR; Rodrigues NP
    Stem Cell Reports; 2019 Aug; 13(2):291-306. PubMed ID: 31378673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia stem cells.
    Dick JE
    Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia.
    Laverdière I; Boileau M; Neumann AL; Frison H; Mitchell A; Ng SWK; Wang JCY; Minden MD; Eppert K
    Blood Cancer J; 2018 Jun; 8(6):52. PubMed ID: 29921955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myeloid leukemia stem cells from genomic and immunological perspectives].
    Goyama S
    Rinsho Ketsueki; 2020; 61(9):1130-1137. PubMed ID: 33162508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
    Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells.
    Pelosi E; Castelli G; Testa U
    Blood Cells Mol Dis; 2015 Dec; 55(4):336-46. PubMed ID: 26460257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.
    Han L; Qiu P; Zeng Z; Jorgensen JL; Mak DH; Burks JK; Schober W; McQueen TJ; Cortes J; Tanner SD; Roboz GJ; Kantarjian HM; Kornblau SM; Guzman ML; Andreeff M; Konopleva M
    Cytometry A; 2015 Apr; 87(4):346-56. PubMed ID: 25598437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities.
    O'Reilly E; Zeinabad HA; Szegezdi E
    Blood Rev; 2021 Nov; 50():100850. PubMed ID: 34049731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells.
    Wang H; Sica RA; Kaur G; Galbo PM; Jing Z; Nishimura CD; Ren X; Tanwar A; Etemad-Gilbertson B; Will B; Zheng D; Fooksman D; Zang X
    Nat Commun; 2024 Jan; 15(1):11. PubMed ID: 38167704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.